Louise Longworth

Louise Longworth is a Reader in Health Economics at Brunel University. She has previously held roles as a Senior Research Fellow at the University of Sheffield, Research Fellow at Brunel University and Technical Advisor at the National Institute for Health and Clinical Excellence (NICE). Louise was awarded a PhD in Health Economics by Brunel University in 2007 (‘Estimating quality adjusted life years where health-state utility data are missing’). She also has an MSc in Health Economics and a BA (Hons) in Economics and Politics; both from the University of York. Her research interests relate to the economic evaluation of health care interventions; in particular, the measurement and valuation of health outcomes. Louise is a member of the NICE Decision Support Unit, which provides research and training support the NICE Technology Appraisal Programme. She has been a member of the EuroQol Group (a multi-national group of researchers interested in measuring quality of life) since 2001, and is a member of its Executive Committee. Starting in 2010, Louise has been appointed as a member of the NICE Technology Appraisal Committee.

 

 

Tosh J, Brazier J, Evans P and Longworth L (2012) A Review of Generic Preference-Based Measures of Health-Related Quality of Life in Visual Disorders, Value in Health, vol 15 (1), pp 118-127. 

 

Longworth L, Sculpher MJ, Bojke L, Tosh JC. Bridging the gap between methods research and the needs of policy makers: A review of the research priorities of the National Institute for Health and Clinical Excellence. Int J Technol Assess Health Care. 27:2. 2011.

 

Tosh J, Longworth L and George E (2011) Utility Values in National Institute for Health and Clinical Excellence (NICE) Technology Appraisals, Value in Health, vol 14, pp 102-9.

 

Longworth L and Longson C (2008) NICE Methodology for Technology Appraisals: Cutting Edge or Tried and Trusted? PharmacoEconomics. 26(9): pp 729-732

 

Kendrick T. Peveler R. Longworth L. Baldwin D. Moore M. Chatwin J. Thornett A. Goddard J. Campbell M. Smith H. Buxton M, Thompson C (2006) Cost-effectiveness and cost-utility of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine: randomised controlled trial. British Journal of Psychiatry. 188, pp.337-45.

 

Longworth L, Young T, Beath SV, Kelly DA, Mistry H, Protheroe SM, Ratcliffe J, Buxton MJ (2006) An economic evaluation of pediatric small bowel transplantation in the United Kingdom. Transplantation. 82(4), pp.508-15.

 

Longworth L, Buxton MJ, Sculpher M and Smith D (2005) Estimating health state preference data from clinical indicators for patients with stable angina. European Journal of Health Economics. 6(4), pp.347-53.

 

Bryan S and Longworth L (2005) Measuring health-related utility: why the disparity between EQ-5D and SF-6D? European Journal of Health Economics 6 (3), pp. 253-260.

 

Ratcliffe J, Young T, Longworth L and Buxton M (2005) An assessment of the impact of informative dropout and nonresponse in measuring health-related quality of life using the EuroQol (EQ-5D) descriptive system Value in Health 8 (1), pp. 53-58.

 

Bishop AJ, Marteau TM, Armstrong A, Chitty LS, Longworth L, Buxton MJ and Berlin C (2004) Women and health care professionals’ preferences for Down’s syndrome screening tests: a conjoint analysis study. British Journal of Obstetrics and Gynaecology 111, pp.775-779.

 

Longworth L and Bryan S (2003) An empirical comparison of EQ-5D and SF-6D in liver transplant patients. Health Economics 12 (12), pp.1061-7.

 

Longworth L, Young T, Buxton MJ, Ratcliffe J, Neuberger J, Burroughs A and Bryan S on behalf of CELT (2003) Midterm cost-effectiveness of the liver transplantation program of England and Wales for three disease groups Liver Transplantation 9 (12), pp.1295-130.